Freya R. Schnabel, MD, discusses the importance of choosing individualized treatment options for patients with breast cancer.
Freya R. Schnabel, MD, director of Breast Surgery at Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, discusses the importance of choosing individualized treatment options for patients with breast cancer.
Today there are more surgery and treatment options than ever before, Schnabel says. Technological advances have allowed patients to gain access to information that will help them better understand both their disease and their treatments. However, Schnabel says, there is no substitute for a good conversation between the doctor and patient.
Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium
January 16th 2023Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.
FDA Approves Adjuvant Ribociclib Plus AI Therapy for HR+, HER2- Breast Cancer
September 17th 2024The Food and Drug Administration approved ribociclib plus an aromatase inhibitor for hormone receptor (HR)–positive, HER2-negative stage II and III early breast cancer that has a high risk of recurrence.